Erivan, Roger
Bourzat, Nicolas
Yessaad, Mouloud
Villatte, Guillaume
descamps, Stéphane
Boisgard, Stéphane
Chennell, Philip https://orcid.org/0000-0001-8086-7517
Article History
Received: 2 January 2025
Accepted: 12 August 2025
First Online: 27 August 2025
Compliance with ethical standards
:
: This in-vitro work was funded by the authors’ institution (except for the dalbavancin vials that were provided free of charge by ADVANZ PHARMA). It did not involve human or animal participants. The authors do not have any conflicts of interest (relating directly or indirectly to the study) to disclose.